Pharma Journalist 9001 posts 0 comments

Lundbeck has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for Lu AH69593, its investigational oral orexin 2 receptor agonist being developed to treat…
Read More...

Affinia Therapeutics has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for its investigational gene therapy AFTX-201, marking another regulatory…
Read More...

BeOne Medicines has announced a $300 million investment to expand its flagship manufacturing and research facility in Hopewell, New Jersey, strengthening its U.S. production…
Read More...

Kairos Pharma has announced a strategic collaboration with Bayer to evaluate a new combination treatment approach for metastatic castration-resistant prostate cancer (mCRPC) that has…
Read More...

Cellares and Papillon Therapeutics have announced a strategic collaboration to automate the manufacturing of PPL-001, an investigational gene-edited cell therapy being developed to…
Read More...

GSK has received U.S. Food and Drug Administration (FDA) approval for Jideytro (zidesamtinib), a next-generation targeted therapy for adults with locally advanced or metastatic…
Read More...

Crystalys Therapeutics has secured $130 million in an oversubscribed Series B financing round to support the late-stage clinical development and commercialization of its lead gout…
Read More...

Evogene Ltd. and South Korea-based biotechnology company ELEO Inc. have entered into a strategic scientific collaboration to develop next-generation oral small-molecule therapies…
Read More...

Lonza and Engitix have entered into a licensing agreement aimed at accelerating the development of next-generation antibody-drug conjugates (ADCs), combining Lonza’s established drug…
Read More...

Samsung Biologics has announced an agreement to acquire Swiss contract development and manufacturing organization (CDMO) PolyPeptide Group AG in an all-cash transaction valued at…
Read More...